» Articles » PMID: 23386720

Critical Regulation of MiR-200/ZEB2 Pathway in Oct4/Sox2-induced Mesenchymal-to-epithelial Transition and Induced Pluripotent Stem Cell Generation

Overview
Specialty Science
Date 2013 Feb 7
PMID 23386720
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

Fibroblasts can be reprogrammed to induced pluripotent stem cells (iPSCs) by application of transcription factors octamer-binding protein 4 (Oct4), SRY-box containing gene 2 (Sox2), Kruppel-like factor 4 (Klf4), and c-Myelocytomatosis oncogene (c-Myc) (OSKM), but the underlying mechanisms remain unclear. Here, we report that exogenous Oct4 and Sox2 can bind at the promoter regions of mir-141/200c and mir-200a/b/429 cluster, respectively, and induce the transcription activation of miR-200 family during the OSKM-induced reprogramming. Functional suppression of miR-200s with specific inhibitors significantly represses the OSKM-caused mesenchymal-to-epithelial transition (MET, an early event in reprogramming of fibroblasts to iPSCs) and iPSC generation, whereas overexpression of miR-200s promotes the MET and iPSC generation. Mechanistic studies showed that miR-200s significantly repress the expression of zinc finger E-box binding homeobox 2 (ZEB2) through directly targeting its 3' UTR and direct inhibition of ZEB2 can mimic the effects of miR-200s on iPSC generation and MET process. Moreover, the effects of miR-200s during iPSC generation can be blocked by ZEB2 overexpression. Collectively, our findings not only reveal that members of the miR-200 family are unique mediators of the reprogramming factors Oct4/Sox2, but also demonstrate that the miR-200/ZEB2 pathway as one critical mechanism of Oct4/Sox2 to induce somatic cell reprogramming at the early stage.

Citing Articles

A Boolean model explains phenotypic plasticity changes underlying hepatic cancer stem cells emergence.

Hernandez-Magana A, Bensussen A, Martinez-Garcia J, Alvarez-Buylla E NPJ Syst Biol Appl. 2024; 10(1):99.

PMID: 39223160 PMC: 11369243. DOI: 10.1038/s41540-024-00422-9.


Engineering principles for rationally design therapeutic strategies against hepatocellular carcinoma.

Hernandez-Magana A, Bensussen A, Martinez-Garcia J, Alvarez-Buylla E Front Mol Biosci. 2024; 11:1404319.

PMID: 38939509 PMC: 11208463. DOI: 10.3389/fmolb.2024.1404319.


Oviductal extracellular vesicles miRNA cargo varies in response to embryos and their quality.

Hamdi M, Sanchez J, Fernandez-Fuertes B, Camara D, Bollwein H, Rizos D BMC Genomics. 2024; 25(1):520.

PMID: 38802796 PMC: 11129498. DOI: 10.1186/s12864-024-10429-5.


The occurrence and development of induced pluripotent stem cells.

Chen Y, Li M, Wu Y Front Genet. 2024; 15:1389558.

PMID: 38699229 PMC: 11063328. DOI: 10.3389/fgene.2024.1389558.


Altered Phenotypes of Breast Epithelial × Breast Cancer Hybrids after ZEB1 Knock-Out.

Merckens A, Sieler M, Keil S, Dittmar T Int J Mol Sci. 2023; 24(24).

PMID: 38139138 PMC: 10744253. DOI: 10.3390/ijms242417310.


References
1.
Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

2.
Mongroo P, Rustgi A . The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol Ther. 2010; 10(3):219-22. PMC: 3040834. DOI: 10.4161/cbt.10.3.12548. View

3.
Peter M . Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle. 2009; 8(6):843-52. PMC: 2688687. DOI: 10.4161/cc.8.6.7907. View

4.
Li Z, Rana T . Using microRNAs to enhance the generation of induced pluripotent stem cells. Curr Protoc Stem Cell Biol. 2012; Chapter 4:Unit 4A.4. DOI: 10.1002/9780470151808.sc04a04s20. View

5.
Kang L, Wang J, Zhang Y, Kou Z, Gao S . iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell. 2009; 5(2):135-8. DOI: 10.1016/j.stem.2009.07.001. View